Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 92

1.

Modified ES / OP9 co-culture protocol provides enhanced characterization of hematopoietic progeny.

Lynch MR, Gasson JC, Paz H.

J Vis Exp. 2011 Jun 7;(52). pii: 2559. doi: 10.3791/2559.

2.

Neutralizing monoclonal antibody to periostin inhibits ovarian tumor growth and metastasis.

Zhu M, Saxton RE, Ramos L, Chang DD, Karlan BY, Gasson JC, Slamon DJ.

Mol Cancer Ther. 2011 Aug;10(8):1500-8. doi: 10.1158/1535-7163.MCT-11-0046. Epub 2011 Jun 13.

3.

Vascular remodeling of the vitelline artery initiates extravascular emergence of hematopoietic clusters.

Zovein AC, Turlo KA, Ponec RM, Lynch MR, Chen KC, Hofmann JJ, Cox TC, Gasson JC, Iruela-Arispe ML.

Blood. 2010 Nov 4;116(18):3435-44. doi: 10.1182/blood-2010-04-279497. Epub 2010 Aug 10.

PMID:
20699440
4.

Periostin promotes ovarian cancer angiogenesis and metastasis.

Zhu M, Fejzo MS, Anderson L, Dering J, Ginther C, Ramos L, Gasson JC, Karlan BY, Slamon DJ.

Gynecol Oncol. 2010 Nov;119(2):337-44. doi: 10.1016/j.ygyno.2010.07.008. Epub 2010 Aug 4.

PMID:
20688362
5.

The homeobox gene Hhex regulates the earliest stages of definitive hematopoiesis.

Paz H, Lynch MR, Bogue CW, Gasson JC.

Blood. 2010 Aug 26;116(8):1254-62. doi: 10.1182/blood-2009-11-254383. Epub 2010 May 14.

6.

Fate tracing reveals the endothelial origin of hematopoietic stem cells.

Zovein AC, Hofmann JJ, Lynch M, French WJ, Turlo KA, Yang Y, Becker MS, Zanetta L, Dejana E, Gasson JC, Tallquist MD, Iruela-Arispe ML.

Cell Stem Cell. 2008 Dec 4;3(6):625-36. doi: 10.1016/j.stem.2008.09.018.

7.

Modeling notch signaling in normal and neoplastic hematopoiesis: global gene expression profiling in response to activated notch expression.

Ganapati U, Tan HT, Lynch M, Dolezal M, de Vos S, Gasson JC.

Stem Cells. 2007 Aug;25(8):1872-80. Epub 2007 Apr 26.

8.

Expression of c-Fes protein isoforms correlates with differentiation in myeloid leukemias.

Carlson A, Berkowitz JM, Browning D, Slamon DJ, Gasson JC, Yates KE.

DNA Cell Biol. 2005 May;24(5):311-6.

PMID:
15869408
9.

Why cancer centers matter.

Gasson JC.

Cancer Biol Ther. 2005 Apr;4(4):493-5. Epub 2005 Apr 28. No abstract available.

PMID:
15846071
10.

Spatial and temporal changes in the subcellular localization of the nuclear protein-tyrosine kinase, c-Fes.

Carlson A, Yates KE, Slamon DJ, Gasson JC.

DNA Cell Biol. 2005 Apr;24(4):225-34.

PMID:
15812239
11.

Identification of novel functional regions important for the activity of HOXB7 in mammalian cells.

Yaron Y, McAdara JK, Lynch M, Hughes E, Gasson JC.

J Immunol. 2001 Apr 15;166(8):5058-67.

12.

Differential gene expression between normal and tumor-derived ovarian epithelial cells.

Ismail RS, Baldwin RL, Fang J, Browning D, Karlan BY, Gasson JC, Chang DD.

Cancer Res. 2000 Dec 1;60(23):6744-9.

13.

Notch signaling enhances survival and alters differentiation of 32D myeloblasts.

Tan-Pertel HT, Walker L, Browning D, Miyamoto A, Weinmaster G, Gasson JC.

J Immunol. 2000 Oct 15;165(8):4428-36.

14.

Constitutive HOXA5 expression inhibits erythropoiesis and increases myelopoiesis from human hematopoietic progenitors.

Crooks GM, Fuller J, Petersen D, Izadi P, Malik P, Pattengale PK, Kohn DB, Gasson JC.

Blood. 1999 Jul 15;94(2):519-28.

PMID:
10397719
15.

The Notch/Jagged pathway inhibits proliferation of human hematopoietic progenitors in vitro.

Walker L, Lynch M, Silverman S, Fraser J, Boulter J, Weinmaster G, Gasson JC.

Stem Cells. 1999;17(3):162-71.

16.

Characterization of HOX gene expression during myelopoiesis: role of HOX A5 in lineage commitment and maturation.

Fuller JF, McAdara J, Yaron Y, Sakaguchi M, Fraser JK, Gasson JC.

Blood. 1999 May 15;93(10):3391-400.

PMID:
10233891
18.

Analysis of Fes kinase activity in myeloid cell growth and differentiation.

Yates KE, Crooks GM, Gasson JC.

Stem Cells. 1996 Nov;14(6):714-24.

19.

Role of c-Fes in normal and neoplastic hematopoiesis.

Yates KE, Gasson JC.

Stem Cells. 1996 Jan;14(1):117-23. Review.

20.
21.

Human c-FES is a nuclear tyrosine kinase.

Yates KE, Lynch MR, Wong SG, Slamon DJ, Gasson JC.

Oncogene. 1995 Mar 16;10(6):1239-42.

PMID:
7700650
22.

The role of the homeobox gene, HOX B7, in human myelomonocytic differentiation.

Lill MC, Fuller JF, Herzig R, Crooks GM, Gasson JC.

Blood. 1995 Feb 1;85(3):692-7.

PMID:
7530503
23.

Transactivation of cellular genes by human retroviruses.

Rosenblatt JD, Miles S, Gasson JC, Prager D.

Curr Top Microbiol Immunol. 1995;193:25-49. Review.

PMID:
7648877
24.

Production of functional myeloid cells from CD34-selected hematopoietic progenitor cells using a clinically relevant ex vivo expansion system.

Lill MC, Lynch M, Fraser JK, Chung GY, Schiller G, Glaspy JA, Souza L, Baldwin GC, Gasson JC.

Stem Cells. 1994 Nov;12(6):626-37.

PMID:
7533581
26.
27.

Characterization of a cell-type-restricted negative regulatory activity of the human granulocyte-macrophage colony-stimulating factor gene.

Fraser JK, Guerra JJ, Nguyen CY, Indes JE, Gasson JC, Nimer SD.

Mol Cell Biol. 1994 Mar;14(3):2213-21.

29.

Signal transduction by granulocyte-macrophage colony-stimulating factor and interleukin-3 receptors.

Sakamoto KM, Mignacca RC, Gasson JC.

Receptors Channels. 1994;2(3):175-81. Review.

PMID:
7874444
30.
31.

Phenotypic characterization of the human fibrous histiocytoma giant cell tumor (GCT) cell line and its cytokine repertoire.

Liesveld JL, Rush S, Kempski MC, Turner AR, Brennan JK, Gasson JC, Abboud CN.

Exp Hematol. 1993 Sep;21(10):1342-52.

PMID:
7689482
32.

HTLV-I and HTLV-II tax trans-activate the human EGR-1 promoter through different cis-acting sequences.

Sakamoto KM, Nimer SD, Rosenblatt JD, Gasson JC.

Oncogene. 1992 Nov;7(11):2125-30.

PMID:
1359492
33.

Clinical applications of human granulocyte-macrophage colony-stimulating factor.

Sakamoto KM, Gasson JC.

Int J Cell Cloning. 1991 Nov;9(6):531-41. Review.

PMID:
1770227
34.
35.

5' upstream sequence and genomic structure of the human primary response gene, EGR-1/TIS8.

Sakamoto KM, Bardeleben C, Yates KE, Raines MA, Golde DW, Gasson JC.

Oncogene. 1991 May;6(5):867-71.

PMID:
2052361
36.

Molecular physiology of granulocyte-macrophage colony-stimulating factor.

Gasson JC.

Blood. 1991 Mar 15;77(6):1131-45. Review. No abstract available.

PMID:
2001448
37.

The biology and clinical applications of granulocyte-macrophage colony-stimulating factor.

Sakamoto KM, Golde DW, Gasson JC.

J Pediatr. 1991 Mar;118(3):S17-20. Review.

PMID:
1999769
38.

Characterization of the soluble human granulocyte-macrophage colony-stimulating factor receptor complex.

DiPersio JF, Hedvat C, Ford CF, Golde DW, Gasson JC.

J Biol Chem. 1991 Jan 5;266(1):279-86.

39.

Recombinant human erythroid potentiating activity enhances the effect of erythropoietin in mice.

Niskanen E, Gasson JC, Egrie J, Wipf K, Golde DW.

Eur J Haematol. 1990 Nov;45(5):267-70.

PMID:
2261953
40.

Human granulocyte colony-stimulating factor: biologic activities and receptor characterization on hematopoietic cells and small cell lung cancer cell lines.

Avalos BR, Gasson JC, Hedvat C, Quan SG, Baldwin GC, Weisbart RH, Williams RE, Golde DW, DiPersio JF.

Blood. 1990 Feb 15;75(4):851-7.

PMID:
1689190
41.

Human granulocyte-macrophage colony-stimulating factor (GM-CSF): regulation of expression.

Gasson JC, Fraser JK, Nimer SD.

Prog Clin Biol Res. 1990;338:27-41. Review.

PMID:
2189139
42.

The biology of human granulocyte-macrophage colony-stimulating factor (GM-CSF).

Gasson JC, Baldwin GC, Sakamoto KM, DiPersio JF.

Prog Clin Biol Res. 1990;352:375-84. Review. No abstract available.

PMID:
2169634
43.

Multiple mechanisms control the expression of granulocyte-macrophage colony-stimulating factor by human fibroblasts.

Nimer SD, Gates MJ, Koeffler HP, Gasson JC.

J Immunol. 1989 Oct 1;143(7):2374-7.

PMID:
2674282
45.

Effects of human GM-CSF on neutrophil degranulation in vitro.

Kaufman SE, DiPersio JF, Gasson JC.

Exp Hematol. 1989 Aug;17(7):800-4.

PMID:
2502423
46.

Genetic analysis of the human tumor necrosis factor alpha/cachectin promoter region in a macrophage cell line.

Economou JS, Rhoades K, Essner R, McBride WH, Gasson JC, Morton DL.

J Exp Med. 1989 Jul 1;170(1):321-6.

47.

Activation of the GM-CSF promoter by HTLV-I and -II tax proteins.

Nimer SD, Gasson JC, Hu K, Smalberg I, Williams JL, Chen IS, Rosenblatt JD.

Oncogene. 1989 Jun;4(6):671-6.

PMID:
2660069
48.

Nonhematopoietic tumor cells express functional GM-CSF receptors.

Baldwin GC, Gasson JC, Kaufman SE, Quan SG, Williams RE, Avalos BR, Gazdar AF, Golde DW, DiPersio JF.

Blood. 1989 Mar;73(4):1033-7.

PMID:
2537665
49.

Colony-stimulating factors and host defense.

Weisbart RH, Gasson JC, Golde DW.

Ann Intern Med. 1989 Feb 15;110(4):297-303. Review.

PMID:
2536530
50.

Characterization of the priming effects of human granulocyte-macrophage colony-stimulating factor on human neutrophil leukotriene synthesis.

DiPersio JF, Naccache PH, Borgeat P, Gasson JC, Nguyen MH, McColl SR.

Prostaglandins. 1988 Nov;36(5):673-91.

PMID:
3148964

Supplemental Content

Loading ...
Support Center